All pages
- Absolute risk
- Absolute risk reduction
- Accelerated approval
- Access
- Accessibility
- Accuracy
- Acquisition cost
- Action research
- Additive model
- Adoption
- Adverse effect
- Adverse event
- Adverse reaction
- Affordability
- Allocation concealment
- Allocative efficiency
- Alpha (α)
- Analytic perspective
- Analytical validation
- Annualisation
- Applicability
- Appropriate
- Appropriateness
- Arithmetic mean
- Assay
- Assessment
- Assistive products
- Attrition bias
- Audit
- Autonomy
- Average cost
- Bayesian analysis
- Bayesian clinical trial
- Bayesian statistics
- Before-and-after study
- Benchmarking
- Best interest standard
- Beta (β)
- Bias
- Bibliographic database
- Big data
- Binary data
- Bioethics
- Biomarker
- Biomarker (or biological marker)
- Blinding
- Budget impact analysis
- CINAHL (Cumulative Index to Nursing and Allied Health Literature)
- COA
- COU
- Candidate surrogate endpoint
- Capital cost
- Capital medical devices
- Carer
- Case
- Case-control study
- Case-mix
- Case report
- Case series
- Case study
- Categorical data
- Causal pathway
- Causality
- Citation
- ClinRO
- Clinical benefit
- Clinical effectiveness
- Clinical guideline
- Clinical outcome
- Clinical outcome assessment
- Clinical pathway
- Clinical practice guidelines
- Clinical predicton
- Clinical significance
- Clinical trial
- Clinical utility
- Clinical validation
- Clinician-reported outcome
- Cluster randomized trials
- Cochrane Central Register of Controlled Trials (CENTRAL)
- Cochrane Database of Methodology Reviews (CDMR)
- Cochrane Database of Systematic Reviews (CDSR)
- Cochrane Methodology Register (CMR)
- Cochrane library
- Cochrane review
- Cohort study
- Cointervention
- Comorbidity
- Comparator
- Compliance
- Concealment of allocation
- Concurrent control
- Conditional coverage
- Confidence interval (CI)
- Confidence profile method
- Confidentiality
- Conflict of interest
- Conflict of interest declaration
- Confounder
- Consensus development
- Consensus report
- Consequence
- Consumer
- Consumer advocate
- Contamination
- Context
- Context bias
- Contingency table
- Contingent valuation
- Continuous data
- Contraindication
- Control
- Control group
- Controlled clinical trial
- Controlled vocabulary
- Correlation coefficient
- Cost
- Cost-benefit analysis
- Cost-consequence analysis (CCA)
- Cost-effectiveness acceptability curve (CEAC)
- Cost-effectiveness analysis (CEA)
- Cost-minimization analysis (CMA)
- Cost-of-illness analysis
- Cost-utility analysis (CUA)
- Cost of lost time
- Cost per QALY
- Coverage with evidence development
- Credible interval
- Critical appraisal
- Cross-sectional study
- Crossover bias
- Crossover design
- Crossover trial
- Cumulative meta-analysis
- Current Contents
- DALY
- Database
- Decision analysis
- Decision tree
- Degree of freedom
- Delphi technique
- Detection bias
- Development steps
- Diagnosis
- Diagnostic accuracy
- Diagnostic impact
- Diagnostic test efficacy
- Dichotomous data
- Diffusion of innovation
- Digital health
- Dilemma
- Direct cost
- Direct medical cost
- Direct non-medical cost
- Disability-adjusted life year (DALY)
- Discount rate
- Discounting
- Discrete data
- Disease management
- Disinvestment
- Disruptive technology
- Dissemination
- Distribution
- Dominance
- Double-blind
- EHealth
- EMBASE (Excerpta Medica Database) (en)
- EMTREE (Excerpta Medica Tree)
- Early Advice
- Early HTA
- Early Value Proposition
- Early awareness and alert system
- Early dialog
- Early dialogue
- Early warning system
- Economic evaluation
- Economic model
- Effect size
- Effectiveness
- Efficacy
- Efficiency
- Efficient frontier
- Emerging health technology
- Empirical
- Endpoint
- Epidemiology
- Equipoise
- Equity
- Equivalence trial
- Estimate of effect
- Ethics
- EuroScan
- Evaluation research
- Event rate
- Evidence-based decision making
- Evidence-based health care
- Evidence-based medicine
- Evidence table
- Explanatory trial
- External validity
- Extrapolation
- FY
- Factorial design
- Factual database
- False negative error
- False positive error
- Field evaluation
- Fiscal year
- Fixed-effect model
- Focus group
- Follow-up
- Formulary
- Friction-cost method
- Funnel plot
- Future health care cost
- Generalizability
- Glossary and Tools
- Gold standard
- Grey literature
- Grounded theory
- Guideline
- HTA database
- HTA report
- HTAi
- HTM
- Handsearching
- Health-related quality of life (HRQL, HRQoL, QOL)
- Health Technology Management
- Health Utilities Index (HUI®)
- Health economics
- Health in all policies
- Health needs assessment
- Health outcome
- Health services research
- Health status
- Health technology
- Health technology assessment
- Healthy-years equivalent (HYE)
- Hermeneutics
- Heterogeneity
- HiAP
- Hierarchy of evidence
- Historical control
- Historical control study
- HomePage
- Homogeneity
- Horizon Scanning
- Human capital approach (HCA)
- Hypothesis testing
- INAHTA
- ISTAHC
- Impact analysis
- Implementation research
- Incidence
- Incremental cost
- Incremental cost-effectiveness ratio (ICER)
- Index Medicus
- Indication
- Indirect cost
- Individual patient data
- Informed choice
- Informed consent
- Intangible cost
- Integrative study
- Intention-to-treat (ITT) analysis
- Inter-rater reliability
- Interim analysis
- Intermediate outcome
- Internal validity
- International Network of Agencies for Health Technology Assessment (INAHTA)
- International Society of Technology Assessment in Health Care (ISTAHC)
- Interrupted time series
- Intervention study
- Interviewer bias
- Intra-rater reliability
- Investigational device exemption (IDE)
- Investigational new drug application (IND)
- Justice
- Kappa statistic
- Knowledge brokering
- Language bias
- Large simple trial
- Level of evidence
- Licensing
- Likelihood ratio
- Literature review
- Living HTA
- Log-odds ratio
- Logic model
- Logistic model
- MEDLARS (Medical Literature Analysis and Retrieval System)
- MEDLINE (MEDlars onLINE)
- MHealth
- Magnitude of treatment effect
- Main Page
- Malpractice
- Managed entry
- Mantel-Haenszel test
- Marginal benefit
- Marginal cost
- Markov chain Monte Carlo (MCMC)
- Markov model
- Masking
- Maturity Readiness
- Mean
- Measurement bias
- Median
- Medical Subject Headings (MeSH)
- Meta-analysis
- Meta-regression
- Methodological quality
- Mini-HTA
- Minimization
- Misclassification
- Monte Carlo simulation
- Mortality rate
- Moving target
- Moving target problem
- Multiple regression
- Multiple testing
- Multiplicative model
- N of 1 trial
- Narrative review
- Natural history
- Negative predictive value (NPV)
- Negative study
- Net benefit
- New drug application (NDA)
- New health technology
- Nominal group technique
- Non-experimental study
- Non-randomized controlled trial
- Null hypothesis
- Number needed to harm (NNH)
- Number needed to treat
- Number needed to treat (NNT)
- Observational study
- Obsolete health technology
- Odds
- Odds ratio (OR)
- Open-label trial
- Opportunity cost
- Ordinal data
- Outcome
- Outcomes research